Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Caroline Romanowski has worked on the following 12 EPO patent applications which have been published in the last five years:

EP11305957

Semuloparin for improving the survival of patients with locally advanced cancer

IPC classification:
A61K 31/00, A61K 31/727, A61P 7/02, A61P 35/00
Applicant:
Aventis Pharma S.A.
Agent:
Caroline Romanowski, Sanofi
Agent:
Caroline Romanowski, Sanofi-Aventis
Status:
APPLICATION REFUSED
EP11761652

BIOTINYLATED POLYSACCHARIDES HAVING AN ANTITHROMBOTIC ACTIVITY AND IMPROVED METABOLIC STABILITY

IPC classification:
A61K 31/727, C08B 37/08
Agent:
Caroline Romanowski, Sanofi
Status:
GRANT OF PATENT INTENDED
EP12718395

POLYSACCHARIDES COMPRISING TWO ANTITHROMBIN III-BINDING SITES, PREPARATION THEREOF AND USE THEREOF AS ANTITHROMBOTIC MEDICAMENTS

IPC classification:
A61K 31/727, C08B 37/00
Applicant:
Sanofi, S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
EXAMINATION REQUESTED
EP12719984

SEMULOPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS RECEIVING CHEMOTHERAPY

IPC classification:
A61K 31/00, A61K 31/727, A61P 7/02, A61P 35/00
Applicant:
Aventis Pharma S.A.
Agent:
Caroline Romanowski, Sanofi, S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11738298

AN ANTITUMORAL COMBINATION COMPRISING OMBRABULIN, A TAXANE DERIVATIVE AND A PLATINUM DERIVATIVE

IPC classification:
A61K 31/167, A61K 31/282, A61K 31/337, A61K 31/555, A61K 33/24, A61K 45/06, A61P 35/00
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11730928

SEMULOPARIN FOR USE AS AN ANTITHROMBOTIC TREATMENT IN HIP REPLACEMENT SURGERY WITH IMPROVED SAFETY IN TERMS OF CLINICALLY RELEVANT BLEEDINGS

IPC classification:
A61K 31/727, A61P 7/02
Applicant:
Aventis Pharma S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11727182

SEMULOPARIN FOR THE PREVENTION OF A MORTALITY AND/OR MORBIDITY EVENT IN A PATIENT UNDERGOING MAJOR ORTHOPAEDIC SURGERY

IPC classification:
A61K 31/727, A61P 7/02
Applicant:
Aventis Pharma S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11729952

SEMULOPARIN FOR THE EXTENDED PREVENTION OF A MORTALITY AND/OR MORBIDITY EVENT IN A PATIENT HAVING UNDERGONE HIP FRACTURE SURGERY

IPC classification:
A61K 31/727, A61P 7/02
Applicant:
Aventis Pharma S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13305130

Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients

IPC classification:
A61K 31/277, A61K 31/505, A61P 25/00
Applicant:
Sanofi, S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION REFUSED
EP12702546

IDRABIOTAPARINUX FOR THE TREATMENT OF PULMONARY EMBOLISM AND FOR THE SECONDARY PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS

IPC classification:
A61K 31/7056, A61K 31/715, A61P 7/02
Applicant:
Sanofi, S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14761286

PYRAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF BLADDER CANCER

IPC classification:
A61K 31/437, A61K 31/444, A61K 31/4545, A61P 35/00
Applicant:
Sanofi, S.A.
Agent:
Cabinet Nony
Agent:
Caroline Romanowski, Sanofi
Status:
GRANT OF PATENT INTENDED
EP11746655

DERIVATIVES OF OXADIAZOLE AND PYRIDAZINE, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS

IPC classification:
A61K 31/425, A61P 3/00, C07D 237/20, C07D 271/06
Applicant:
Sanofi, S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature